A stereoselective and scalable synthesis of a conformationally constrained S1P1 agonist

Tetrahedron Letters

Volumn 50, Issue 28, 2009, Pages 4081-4083

  Fix Stenzel, Shannon R ^a   Hayes, Martin E ^a   Zhang, Xiaolei ^a   Wallace, Grier A ^a   Grongsaard, Pintipa ^a   Schaffter, Lisa M ^a   Hannick, Steven M ^a   Franczyk, Thaddeus S ^a   Stoffel, Robert H ^a   Cusack, Kevin P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALCOHOL; CYCLOPENTANE; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; SPHINGOSINE 1 PHOSPHATE AGONIST; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CATALYSIS; CHIRALITY; DRUG CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGENATION; RING CLOSING METATHESIS; STEREOCHEMISTRY;

EID: 66049102946     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.04.099     Document Type: Article

References (26)

1. Pyne S., and Pyne J.N. Biochemistry 349 (2000) 385
2. Rosen H., Sanna G., and Alfonso C. Immunol. Rev. 195 (2003) 160
3. Pettus B.J., Chalfant C.E., and Hannun Y.A. Curr. Mol. Med. 4 (2004) 405
4. Cyster J.G. Annu. Rev. Immunol. 23 (2005) 127
5. Chun J., and Rosen H. Curr. Pharm. Des. 12 (2006) 161
6. Ryan J.J., and Spiegel S. Drug News Perspectives 21 (2008) 89
7. Huwiler A., and Pfeilschifter J. Biochem. Pharmacol. 75 (2008) 1893
8. Kappos L., Antel J., Comi G., Montalban X., O'Connor P., Polman C.H., Haas T., Korn A.A., Karlsson G., and Radue E.W. New Engl. J. Med. 255 (2006) 1124
9. Baumruker T., Billich A., and Brinkmann V. Expert Opin. Investig. Drugs 16 (2007) 283
10. Zhu R., Snyder A.H., Khrarel Y., Schaffter L., Sun Q., Kennedy P.C., Lynch K.R., and Macdonald T.L. J. Med. Chem. 50 (2007) 6428
11. Kato N., Suzuki M., Kanai M., and Shibasaki M. Tetrahedron Lett. 45 (2004) 3147
12. Williams R.M., and Im M.-N. J. Am. Chem. Soc. 113 (1991) 9276
13. Espino C., When P., Chow J., and Du Bois J. J. Am. Chem. Soc. 123 (2001) 6935
14. Maruoka K., and Ooi T. Chem. Rev. 103 (2003) 3013
15. Ooi T., Takeuchi M., Kameda M., and Maruoka K. J. Am. Chem. Soc. 122 (2000) 5228
16. The S,S-ammonium bromide catalyst, [287384-12-7], is commercially available from several vendors including Sigma-Aldrich.
17. Prepared according to the method described in:. Yamanaka M., Arisawa M., Nishida A., and Nakagawa M. Tetrahedron Lett. 43 (2002) 2403
18. Isolated yields of the free amine 5 using the one-pot procedure ranged from 29% to 38% while the two-pot protocol provided 61-72% yield of 5 on multi-gram scale.
19. Garber S.B., Kingsbury J.S., Gray B.L., and Hoveyda A.H. J. Am. Chem. Soc. 122 (2000) 8168
20. Lightfoot A., Schnider P., and Pfaltz A. Angew.Chem., Int. Ed. 37 (1998) 2897
21. Menges F., and Pfaltz A. Adv. Synth. Catal. 344 (2002) 40
22. Both enantiomers of the diphenylphosphinite precatalyst are commercially available from Strem: S,S-[405235-55-4] and R,R-[880262-16-8].
23. Macdonald and co-workers also reported a lack of reactivity using the Pfaltz catalyst on a similar substituted cyclopentene, as described in Ref. 3.
24. Crabtree R.H., Felkin H., and Morris G.E. J. Organomet. Chem. 141 (1977) 205
25. Crabtree R.H. Acc. Chem. Res. 12 (1979) 331
26. Modest mass recovery was observed upon recrystalization from heptane under unoptimized conditions.